慶應義塾大学 · 医学
Uwamino教授の研究室は、感染症の迅速かつ正確な診断を目的とした分子診断技術の開発を主眼としています。特に、SARS-CoV-2の唾液由来RT-PCR検査の有効性や、非結核性アスペルギルス菌やマイコバクテリウム属菌の臨床的意義についての研究が進んでいます。また、結核や非結核性マイコバクテリウム症の迅速同定を可能にするPCR-rSSO法を応用した検査パネル「Myco-Panel」の開発・臨床応用にも貢献しています。
Figures are computed from collected data and may differ slightly.
COVID-19 prevalence has increased worldwide. Reverse transcription (RT)-PCR-based SARS-CoV-2 detection has majorly contributed to COVID-19 diagnosis. Although nasopharyngeal swab samples are commonly used for RT-PCR, infection risk is high among the healthcare personnel during sample collection. Saliva, which can be self-collected by patients even at home, has been proposed as a sample for RT-PCR-based SARS-CoV-2 detection, thus potentially reducing the infection risk among healthcare personnel.
Low serum E2 levels were strongly related to MAC-LD in postmenopausal women.
Our results show that H. cinaedi infections are quite common in immunocompetent community-dwelling individuals.
The prevalence of nontuberculous mycobacterial diseases is increasing worldwide, and tuberculosis remains highly prevalent. Rapid and accurate microbial diagnoses of both tuberculosis and nontuberculous mycobacterial infections are required. A novel PCR-reverse sequence-specific oligonucleotide probe (PCR-rSSO) method-based mycobacterial detection panel (Myco-Panel) test was developed for the rapid identification of 30 mycobacterial species and subspecies. Clinical respiratory samples were colle
Open papers in the app to read, cite, and organize with AI.
